The trial is to test the safety and efficacy of Pfizer’s COVID-19 vaccine on 2,000 children across the country between the ages of 12 and 15.
Sophie Holland is one of about 100 children enrolled by Duke for the study.
Nearly one-third of people with ‘mild’ COVID-19 still struggle with symptoms months later, the study finds
The 12-year-old does not know if she received the vaccine or a placebo for the study. But she said she had side effects after the second dose, so she believes she got the vaccine.
“Like 10 to 12 hours after I got it, I got chills and had fever the next day,” Holland said. “But it was not too bad. It only took a few days and then it was all over. ‘
Cancer patients are ‘frustrated’ because the state’s refurbished priorities further vaccinate them on the COVID-19 waiting list
Holland’s father, Thomas, is an infectious doctor at Duke.
“I think there is evidence that the mRNA vaccines are very, very safe in millions and millions of doses in adults,” said Dr. Holland said. “So I felt really good about the likely safety profile in her age group.”
Pregnant women in trial receive first dose of COVID-19 vaccination
‘I feel happy to contribute to all the scientific stuff and when I first heard about it, I realized that it can be risky because we do not know much about how it affects children, but I realized that what we need to do . to learn about it, take part in the trial, ‘said Sophie Holland.
Holland is drawn blood and nose swabs every few weeks as part of the trial.
“That’s all I’m proud of her and I was with her during every visit and saw her do things, and that’s part of her contribution to science,” said Dr. Holland said.
They no longer enroll children for the study.
Duke hopes to participate in the next phase of the study for children under 11 years of age. It can start as early as spring.
Copyright © 2021 WTVD-TV. All rights reserved.